Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyloprim Augmentation for Prevention of Mania in Bipolar Disorder
NCT00732251Phase 4Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Aug 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of allopurinol in bipolar disorder (BD), sponsored by Cedars-Sinai Medical Center. Started Aug 2008; status: terminated.
02
Drugs
allopurinol
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00732251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732251.